AtriCure (ATRC) Net Income towards Common Stockholders (2010 - 2026)
AtriCure (ATRC) reported Net Income towards Common Stockholders of $108000.0 for Q1 2026, up 101.6% year-over-year from $53571.2 in Q1 2025, and down 93.85% quarter-over-quarter from $1.8 million in Q4 2025.
AtriCure (ATRC) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has 17 years of Net Income towards Common Stockholders data on file, last reported at $108000.0 in Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at $108000.0, up 101.6% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.6 million (up 87.97% YoY), and the FY2025 annual result was -$11.4 million, up 74.39% from the prior year.
- Net Income towards Common Stockholders retreated to $108000.0 in Q1 2026 per ATRC's latest filing, from $1.8 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $1.8 million in Q4 2025 and troughed at -$15.6 million in Q4 2024.
- A 5-year average of -$7.8 million and a median of -$7.9 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2023 and 2025: Net Income towards Common Stockholders tumbled 134.75% in 2023, then jumped 111.28% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$4.2 million in 2022, then plunged by 134.75% to -$9.8 million in 2023, then plunged by 59.04% to -$15.6 million in 2024, then jumped by 111.28% to $1.8 million in 2025, then sank by 93.85% to $108000.0 in 2026.
- Business Quant data shows ATRC's Net Income towards Common Stockholders at $108000.0 in Q1 2026, $1.8 million in Q4 2025, and -$267000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.00 Mn |
| 10 | AtriCure | 1.34 Bn | 1.19 Bn | 109.31 Mn | 108,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | 1.76 Mn |
| Sep 30, 2025 | -267,000.00 |
| Jun 30, 2025 | -6.19 Mn |
| Mar 31, 2025 | -6.75 Mn |
| Dec 31, 2024 | -15.57 Mn |
| Sep 30, 2024 | -7.85 Mn |
| Jun 30, 2024 | -8.01 Mn |
| Mar 31, 2024 | -13.27 Mn |
| Dec 31, 2023 | -9.79 Mn |
| Sep 30, 2023 | -9.06 Mn |
| Jun 30, 2023 | -5.12 Mn |
| Mar 31, 2023 | -6.48 Mn |
| Dec 31, 2022 | -4.17 Mn |
| Sep 30, 2022 | -12.27 Mn |
| Jun 30, 2022 | -14.84 Mn |
| Mar 31, 2022 | -15.18 Mn |
| Dec 31, 2021 | -13.74 Mn |
| Sep 30, 2021 | 97.11 Mn |
| Jun 30, 2021 | -16.25 Mn |